De novo variants in HK1 associated with neurodevelopmental abnormalities and visual impairment
Volkan Okur(MACOM (United States)), Wendy K. Chung(Oregon Health & Science University), Kwame Anyane‐Yeboa(Columbia University Irving Medical Center), Ian D. Krantz(Northwell Health), Dorothy K. Grange(Washington University in St. Louis), Ashley Wilson(Center for Infectious Disease Research), Jonathan Picker(Texas A&M Health Science Center), Brigitte van Oirschot(Utrecht University), Colleen Clark Muraresku(Children's Hospital of Philadelphia), Stephanie A. Coury(Boston Children's Hospital), Kyle Retterer(Geisinger Health System), Amber Begtrup, Aida Telegrafi(GenVec), Linda Manwaring(Washington University in St. Louis), Eric A. Pierce(Broad Institute), Ganka Douglas, Richard van Wijk(Utrecht University), Megan T. Cho, Peter J. Hulick(NorthShore University HealthSystem), Emily Place(MACOM (United States)), Kinga M. Bujakowska(Massachusetts Eye and Ear Infirmary), Holley May(Endeavor Health), Kristin G. Monaghan
Cited by 33
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k